Viatris, Inc. is a global healthcare company, which engages in the provision of healthcare and pharmaceutical products. The company is headquartered in Canonsburg, Pennsylvania and currently employs 30,000 full-time employees.  The firm's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment comprises its operations primarily in North America and Europe. The Greater China segment includes its operations in China, Taiwan and Hong Kong. The JANZ segment reflects its operations in Japan, Australia, and New Zealand. The Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies, including in Asia, Africa, Eastern Europe, Latin America, and the Middle East, as well as the Company’s Antiretroviral medicines (ARV) franchise. Its pipeline and research and development capabilities include expertise in formulation, device development, toxicology, analytical, clinical, bioanalytical, medical affairs, product safety and risk management across a range of therapeutic areas. The company produces oral solid doses, injectables, and products with complex dosage forms.

Viatris, Inc. adalah perusahaan kesehatan global yang bergerak dalam penyediaan produk kesehatan dan farmasi. Kantor pusat perusahaan ini berada di Canonsburg, Pennsylvania, dan saat ini mempekerjakan 30.000 karyawan tetap. Segmen perusahaan mencakup Pasar Maju, Tiongkok Besar, JANZ, dan Pasar Berkembang. Segmen Pasar Maju mencakup operasi utamanya di Amerika Utara dan Eropa. Segmen Tiongkok Besar mencakup operasi di Tiongkok, Taiwan, dan Hong Kong. Segmen JANZ mencerminkan operasi di Jepang, Australia, dan Selandia Baru. Segmen Pasar Berkembang mencakup kehadirannya di lebih dari 125 negara dengan pasar yang berkembang dan ekonomi yang muncul, termasuk di Asia, Afrika, Eropa Timur, Amerika Latin, dan Timur Tengah, serta waralaba obat Antiretroviral (ARV) perusahaan. Saluran produknya dan kemampuan penelitian serta pengembangan mencakup keahlian dalam formulasi, pengembangan perangkat, toksikologi, analisis, klinis, bioanalitik, urusan medis, keselamatan produk, dan manajemen risiko di berbagai area terapeutik. Perusahaan memproduksi dosis padat oral, injeksi, dan produk dengan bentuk dosis yang kompleks.

Viatris

Google

Apple

Microsoft

Amazon

Broadcom

Meta Platforms

JPMorgan

Eli Lilly

Exxon Mobil

Oracle

Johnson & Johnson

ASML

MasterCard

Micron Technology

SPDR S&P500 ETF

Palantir

Costco

Bank of America

Chevron

General Electric

Procter & Gamble

Coca-Cola

AstraZeneca

Vanguard Total Stock Market ETF

Toyota

Caterpillar

Cisco

Goldman Sachs

Lam Research

Merck

Novartis

Raytheon Technologies

Wells Fargo

Philip Morris

Applied Materials

American Express

Royal Bank of Canada

Intel

Abbott

Salesforce

T-Mobile

Shell

Intuitive Surgical

Shopify

Invesco QQQ Trust

TotalEnergies

Blackstone

PepsiCo

Boeing

Verizon

Charles Schwab

Disney

Amgen

QUALCOMM

Texas Instruments

Novo Nordisk

Arista Networks

Lowe's

Capital One

Corning

Southern Copper

Anheuser-Busch Inbev

Honeywell

Sony

Pfizer

Unilever

Deere

Danaher

ServiceNow

Banco Bilbao

Adobe

S&P Global

Palo Alto Networks

ConocoPhillips

Medtronic

Progressive

Chubb

CrowdStrike

Sanofi

Seagate Technology

Vertex Pharmaceuticals

Bristol-Myers Squibb

Comcast

Vanguard Dev Markets ETF

McKesson

Mercadolibre

Starbucks

Enbridge

Carvana

Agnico Eagle

General Dynamics

Vanguard Value ETF

Freeport-McMoRan

Robinhood

Equinor

Nike

Saham Viatris

Tentang Viatris

Statistik Kunci

Insights

Pengguna Lain Sedang Membeli